Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Br J Dermatol. 2010 Aug;163(2):334-9. doi: 10.1111/j.1365-2133.2010.09899.x. Epub 2010 Jun 9.
Data on pregnancy outcomes among women with psoriasis are lacking. However, there are several known comorbidities of psoriasis, including obesity, smoking and depression, each of which increases the risk for negative birth outcomes.
To determine if pregnant women with psoriasis have an excess of potentially modifiable risk factors for adverse pregnancy outcomes.
Prospectively collected data from the Organization of Teratology Information Specialists (OTIS) Autoimmune Diseases in Pregnancy Project were analysed to compare the prevalence of selected risk factors between 170 pregnant women with psoriasis and 158 nondiseased controls.
Women with psoriasis were more likely to be overweight/obese prior to pregnancy (P < 0.0001), to smoke (P < 0.0001), or to have a diagnosis of depression (P = 0.03), and were less likely to have been taking preconceptional vitamin supplements (P = 0.004). After controlling for race/ethnicity and socioeconomic status, women with psoriasis were 2.37 (95% confidence interval 1.45-3.87) times more likely to be overweight/obese as women without psoriasis. Duration of disease, age at onset, measures of disease impact during pregnancy, or use of biologics in pregnancy were not significant predictors of overweight/obesity in the subset of psoriatic women.
Pregnant women with psoriasis may be at increased risk for adverse pregnancy outcomes due to comorbidities or other health behaviours associated with the disease. These should be taken into consideration during clinical treatment of women with psoriasis who are in their childbearing years.
有关银屑病女性妊娠结局的数据尚缺乏。然而,银屑病存在多种已知的合并症,包括肥胖、吸烟和抑郁,这些合并症都会增加不良妊娠结局的风险。
确定银屑病孕妇是否存在过多的潜在可改变的不良妊娠结局的危险因素。
对组织畸形信息专家(OTIS)妊娠自身免疫性疾病项目中前瞻性收集的数据进行分析,比较 170 例银屑病孕妇和 158 例非疾病对照者中选定危险因素的患病率。
银屑病女性在妊娠前更可能超重/肥胖(P<0.0001)、吸烟(P<0.0001)或有抑郁诊断(P=0.03),且更不可能在妊娠前服用维生素补充剂(P=0.004)。在校正种族/民族和社会经济地位后,银屑病女性超重/肥胖的可能性是无银屑病女性的 2.37 倍(95%置信区间 1.45-3.87)。疾病持续时间、发病年龄、妊娠期间疾病影响的测量值或妊娠期间使用生物制剂均不能作为银屑病女性超重/肥胖的显著预测因素。
由于与疾病相关的合并症或其他健康行为,妊娠银屑病女性可能面临更高的不良妊娠结局风险。在治疗处于生育年龄的银屑病女性时,应考虑这些因素。